US equities
|
MU
$901.49
▼-0.38%
NVDA
$216.44
▼-0.30%
SPCX
$146.82
▼-0.77%
TSLA
$375.40
▲+1.99%
META
$689.52
▼-2.26%
SNDK
$1,367.97
▼-0.23%
AAPL
$340.15
▼-0.81%
INTC
$92.00
▼-0.03%
MU
$901.49
▼-0.38%
NVDA
$216.44
▼-0.30%
SPCX
$146.82
▼-0.77%
TSLA
$375.40
▲+1.99%
META
$689.52
▼-2.26%
SNDK
$1,367.97
▼-0.23%
AAPL
$340.15
▼-0.81%
INTC
$92.00
▼-0.03%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about cdd0bcab/b330/5222/aa67/3e9daf29c87a
Recent news which mentions cdd0bcab/b330/5222/aa67/3e9daf29c87a
Axcella's new long COVID medication helps some patients in small trial
August 02, 2022
Tags
Reuters
fox/news/fox/news/newsedge/fox/news/health
fox/business/healthcare
From
FOX Business